← Leaderboards
Linghua Wang
University Of Tx Md Anderson Can Ctr
$3,415,632
Attributed
$9,410,594
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2022–25$10M$7.5M$5M$2.5M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$9,410,594 · 3
By mechanism
U01$6,886,539 · 2
R01$2,524,055 · 1
Top collaborators
- Humam Kadara4 shared
- Pawel K. Mazur4 shared
- Tae Hyun Hwang2 shared
- Mingyao Li2 shared
- Paul F Mansfield2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Humam Kadara$4,695,975
- Jonathan M Kurie$24,221,061
- Shumei Song$2,178,114
- Anil K Sood$29,572,737
- Marina Y Konopleva$11,210,192
Others in their field
Other Rising Stars on “Phenotype”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Michelle Rives · Baylor College Of Medicine$20,650,593
- Suma Babu · Massachusetts General Hospital$20,303,231
- Sabrina Paganoni · Massachusetts General Hospital$20,303,231
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Research focus
PhenotypeComplexTumorCohortMalignant NeoplasmsMolecularCellsEvolutionTranscriptomicsTumor HeterogeneityIn VivoImmunotherapyTumor-Immune System InteractionsExhibitsRecurrenceSiteMouse ModelDistantHeterogeneityEcosystemDiagnosisImmunePropertyMalignant Stomach Neoplasm
Grant awards (10)
Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D)$4,088,788
U01 · FY2025 · CA · contact PI
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$642,253
R01 · FY2025 · CA · contact PI
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development$435,096
U01 · FY2025 · CA
Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D)$1,069,873
U01 · FY2024 · CA · contact PI
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$610,140
R01 · FY2024 · CA · contact PI
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development$411,223
U01 · FY2024 · CA
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$629,409
R01 · FY2023 · CA · contact PI
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development$428,656
U01 · FY2023 · CA
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$642,253
R01 · FY2022 · CA · contact PI
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development$452,903
U01 · FY2022 · CA